A question of ethics: Selling autologous stem cell therapies flaunts professional standards

Stem Cell Research

Volumn 13, Issue 3, 2014, Pages 647-653

  Munsie, Megan ^a   Hyun, Insoo ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELL; ADVERSE OUTCOME; AUTOLOGOUS STEM CELL TRANSPLANTATION; COMMERCIAL PHENOMENA; CONSUMER; ESTHETIC SURGERY; ETHICS; EVIDENCE BASED PRACTICE; EXPECTATION; HUMAN; LIPOSUCTION; MARKETING; MEDICAL PRACTICE; MESENCHYMAL STEM CELL; PATIENT; PATIENT CARE; PATIENT MONITORING; PHYSICIAN; PLASTIC SURGEON; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; PROFESSIONALISM; RESPONSIBILITY; REVIEW; STEM CELL RESEARCH; AUTOTRANSPLANTATION; BIOLOGICAL THERAPY; ECONOMICS; PSYCHOLOGY; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION;

CELL- AND TISSUE-BASED THERAPY; HUMANS; PATIENTS; PHYSICIANS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 84911424206     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.04.014     Document Type: Review

References (46)

1. Abbott A. Stem-cell ruling riles researchers. Nature 2013, 495(7442):418-419.
2. Abbott A. Leaked files slam stem-cell therapy. Nature 2014, 505(7482):139-140. 10.1038/505139a.
3. ABIM Foundation Medical professionalism in the new millennium: a physician charter. Ann. Intern. Med. 2002, 136(3):243-246.
4. Aldhous P. Fight for the right to stem cells. New Sci. 2013, 219(2929):42-45.
5. ASCC: Australian Stem Cell Centre Stem Cell Therapies: Now and in the Future. The Australian Stem Cell Centre Patient Handbook 2009, ASCC, Melbourne, (December).
6. Bianco P. Don't market stem-cell products ahead of proof. Nature 2013, 499(7458). (255-255). 10.1038/499255a.
7. Bianco P., Cao X., Frenette P.S., Mao J.J., Robey P.G., Simmons P.J., Wang C.Y. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 2013, 19(1):35-42. 10.1038/nm.3028.
8. Bianco P., Barker R., Brüstle O., Cattaneo E., Clevers H., Daley G.Q., Smith A. Regulation of stem cell therapies under attack in Europe: for whom the bell tolls. EMBO J. 2013, 32(11):1489-1495. 10.1038/emboj.2013.114.
9. Brody H. The Healer's Power 1992, Yale University Press.
10. Bubela T., Li M.D., Hafez M., Bieber M., Atkins H. Is belief larger than fact: expectations, optimism and reality for translational stem cell research. BMC Med. 2012, 10(1):133. 10.1186/1741-7015-10-133.
11. Caplan A.I., Correa D. The MSC: an injury drugstore. Cell Stem Cell 2011, 9(1):11-15. 10.1016/j.stem.2011.06.008.
12. Cyranoski D. Patients seek stem-cell compensation. Nature News Blog (online 6 July) (Accessed 17 December 2013). http://blogs.nature.com/news/2012/07/patients-seek-stem-cell-compensation.html.
13. Daley G.Q. The promise and perils of stem cell therapeutics. Cell Stem Cell 2012, 10(6):740-749. 10.1016/j.stem.2012.05.010.
14. DeFrancesco L. Adult stem cell therapies walk the line. Nat. Biotechnol. 2012, 30(8):739-741. 10.1038/nbt.2321.
15. DIISR: Department of Innovation, Industry, Science and Research Public attitudes towards biotechnology in Australia (Accessed 17 December 2013). http://www.innovation.gov.au/industry/nanotechnology/PublicAwarenessandEngagement/Documents/AustBioAttitude2010.pdf.
16. Downey R., Geransar R. Stem cell research, publics' and stakeholder views. Health Law Rev. 2008, 16(2):69-85.
17. Eaves F.F., Haeck P.C., Rohrich R.J. ASAPS/ASPS position statement on stem cells and fat grafting. Plast. Reconstr. Surg. 2012, 129(1):285-287. 10.1097/PRS.0b013e3182362caf.
18. GoFundMe Retired NRL player needs adult stem cells (Online 29 July) (Accessed 17 December 2013). http://www.gofundme.com/xm5ag.
19. Hyun I. Therapeutic hope, spiritual distress, and the problem of stem cell tourism. Cell Stem Cell 2013, 12(5):505-507.
20. Hyun I., Lindvall O., Ährlund-Richter L., Cattaneo E., Cavazzana-Calvo M., Cossu G., et al. New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 2008, 3(6):607-609. 10.1016/j.stem.2008.11.009.
21. ISSCR: International Society for Stem Cell Research Guidelines for the clinical translation of stem cells (Accessed 17 December 2013). http://www.isscr.org/docs/default-source/clin-trans-guidelines/isscrglclinicaltrans.pdf.
22. ISSCR Take a closer look at stem cell research treatments (7 December) (Accessed 17 December 2013). http://www.closerlookatstemcells.org.
23. ISSCR Statement on delivery of unproven autologous cell-based interventions to patients (online 11 September) (Accessed 17 December 2013). http://www.isscr.org/docs/default-source/isscr-statements/isscr-acbistatement-091113-fl.pdf.
24. Jabr F. In the flesh: the embedded dangers of untested stem cell cosmetics. Scientific American (17 December) (Accessed 10 November 2013). http://www.scientificamerican.com/article.cfm?id=stem-cell-cosmetics.
25. Kiatpongsan S., Sipp D. Monitoring and regulating offshore stem cell clinics. Science 2009, 323(5921):1564-1565. 10.1126/science.1168451.
26. Lau D., Ogbogu U., Taylor B., Stafinski T., Menon D., Caulfield T. Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell 2008, 3(6):591-594. 10.1016/j.stem.2008.11.001.
27. Li M.D., Atkins H., Bubela T. The global landscape of stem cell clinical trials. Regen. Med. 2013, 9(1):1-13. 10.2217/rme.13.80.
28. Lindvall O., Hyun I. Medical innovation versus stem cell tourism. Science 2009, 324:1664-1665. 10.1126/science.1171749.
29. Margottini L. Italian Parliament orders clinical trial of controversial stem cell treatment. Science Insider (online 22 May) (Accessed 9 April 2014). http://news.sciencemag.org/europe/2013/05/italian-parliament-orders-clinical-trial-controversial-stem-cell-treatment.
30. Margottini L. No point in testing controversial stem cell treatment, Italian panel says. Science Insider (online 12 September) (Accessed 17 December 2013). http://news.sciencemag.org/biology/2013/09/no-point-testing-controversial-stem-cell-treatment-italian-panel-says.
31. Master Z., Caulfield T. Patient booklet: what you need to know about stem cell therapies (Accessed 9 April 2014). http://www.stemcellnetwork.ca/index.php?page=patientbooklet&hl=eng.
32. Master Z., Resnik D.B. Stem-cell tourism and scientific responsibility. EMBO Rep. 2011, 12(10):992-995. 10.1038/embor.2011.156.
33. NSCFA: National Stem Cell Foundation of Australia The Australian Stem Cell Handbook 2013, July, NSCFA, Melbourne, (http://www.stemcellfoundation.net.au/patient-information/handbook [Accessed 17 December 2013]).
34. Ogbogu U., Rachul C., Caulfield T. Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better?. Regen. Med. 2013, 8(3):361-369. 10.2217/rme.13.15.
35. Patients for Stem Cells Tell your Senator - protect our right to adult stem cells (online 14 June) (Accessed 17 December). http://www.patientsforstemcells.org/tell-your-senator-protect-our-right-to-adult-stem-cells/.
36. Petersen A., Seear K. Technologies of hope: techniques of the online advertising of stem cell treatments. New Genet. Soc. 2011, 30(4):329-346.
37. Petersen A., Seear K., Munsie M. Therapeutic journeys: the hopeful travails of stem cell tourists. Sociol. Health Illn 2013, (Epub ahead of print). 10.1111/1467-9566.12092.
38. Ryan K.A., Sanders A.N., Wang D.D., Levine A.D. Tracking the rise of stem cell tourism. Regen. Med. 2010, 5(1):27-33. 10.2217/rme.09.70.
39. Sakagami H., Yoneyama K. 'Stem cell treatments' mar trust The Japan News (online 5 December) (Accessed 17 December 2013). http://the-japan-news.com/news/article/0000846173.
40. Shen H. Stricter standards sought to curb stem-cell confusion. Nature 2013, 499:389. 10.1038/499389a.
41. Sipp D. Direct-to-consumer stem cell marketing and regulatory responses. Stem Cells Transl. Med. 2013, 2(9):638-640. 10.5966/sctm.2013-0040.
42. Smith S., Neaves W., Teitelbaum S. Adult stem cell treatments for diseases. Science 2006, 313(5786):439.
43. Stem Cell China News Heart disease - Kevin (online 16 February) (Accessed 17 December 2013). http://stemcellschina.com/es/heart-disease-kevin.
44. Thirabanjasak D., Tantiwongse K., Thorner P.S. Angiomyeloproliferative lesions following autologous stem cell therapy. J. Am. Soc. Nephrol. 2010, 21(7):1218-1222. 10.1681/ASN.2009111156.
45. Trickett A.E., Wall D.M. Regulation of cellular therapy in Australia. Pathology 2011, 43(6):627-634.
46. United States v.Regenerative Sciences and LLC (12-5254 (D.C. Cir. 2014) (On line 4 February)) (Accessed 9 April). http://www.gpo.gov/fdsys/pkg/USCOURTS-dcd-1_10-cv-01327.